ADVANCED MELANOMA
Clinical trials for ADVANCED MELANOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MELANOMA trials appear
Sign up with your email to follow new studies for ADVANCED MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Boosting the Body's army: can a second drug help immune therapy fight deadly melanoma?
Disease control OngoingThis study tested whether adding a drug called GM-CSF (sargramostim) to an existing immune-boosting cancer drug (ipilimumab) could help patients with advanced melanoma live longer. The trial involved 245 adults whose melanoma could not be removed by surgery. Researchers compared …
Matched conditions: ADVANCED MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New combo therapy trial offers hope for HIV patients with advanced cancers
Disease control OngoingThis is a small, early-stage safety study testing a combination of two cancer drugs, nivolumab and cabozantinib, in people living with HIV who have advanced solid tumors. The main goal is to see if the two-drug combination is safe and tolerable for this specific patient group. Re…
Matched conditions: ADVANCED MELANOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug trial offers hope for advanced melanoma patients out of options
Disease control OngoingThis study is testing an experimental drug called botensilimab, alone and in combination with another drug, for people with advanced skin cancer (melanoma) that has continued to grow despite previous immunotherapy treatments. The goal is to see if the new treatment can shrink tum…
Matched conditions: ADVANCED MELANOMA
Phase: PHASE2 • Sponsor: Agenus Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Scientists test Triple-Threat drug cocktail in fight against tough cancers
Disease control OngoingThis early-stage study is testing a new three-drug combination for people with advanced melanoma or kidney cancer. The main goal is to find a safe and tolerable dose of the new drug, APX005M, when given with two existing immunotherapy drugs. Researchers will enroll about 26 patie…
Matched conditions: ADVANCED MELANOMA
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New combo therapy fights back when melanoma outsmarts standard treatment
Disease control OngoingThis study is testing whether a two-part immunotherapy can help patients with advanced melanoma whose cancer has continued to grow despite standard immune-based treatments. It combines a modified virus injected directly into tumors (T-VEC) with an intravenous drug (pembrolizumab)…
Matched conditions: ADVANCED MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 18, 2026 18:34 UTC
-
Trial aims to cut cancer treatment time in half using scans
Disease control OngoingThis study is testing if doctors can safely stop a standard immunotherapy treatment early for people with advanced melanoma. It uses special PET scans and sometimes a biopsy taken after one year of treatment to check if the cancer is under control. If the scan and biopsy show no …
Matched conditions: ADVANCED MELANOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC
-
Virus therapy offered to fight tough melanoma cases
Disease control NO_LONGER_AVAILABLEThis program provided early access to an experimental treatment combining a modified virus (VO) with an existing immunotherapy drug (nivolumab) for adults with advanced skin cancer (melanoma) that had worsened despite standard treatment. The goal was to see if the virus could hel…
Matched conditions: ADVANCED MELANOMA
Sponsor: Replimune Inc. • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
Scientists test supercharged immune cells to fight tough skin cancer
Disease control OngoingThis is an early safety study for people with advanced melanoma that has stopped responding to standard treatments. Doctors will collect a patient's own tumor-fighting immune cells, grow them in a lab, and then infuse them back into the patient along with a new drug (ANV419) desi…
Matched conditions: ADVANCED MELANOMA
Phase: PHASE1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC